2013
DOI: 10.1016/j.neulet.2012.11.052
|View full text |Cite
|
Sign up to set email alerts
|

Honokiol inhibits the inflammatory reaction during cerebral ischemia reperfusion by suppressing NF-κB activation and cytokine production of glial cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
58
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 98 publications
(59 citation statements)
references
References 23 publications
1
58
0
Order By: Relevance
“…The factor NF-κB (Section 3.1) promotes the transcription of genes involved in pro-inflammatory responses. In macrophages, NF-κB is activated by inflammatory extracellular signals such as LPS, IL-1 and tumor necrosis factor α (TNF-α), and regulates a number of inflammatory genes, inducing further inflammatory mediators, including NO· and cytokines (Zhang et al, 2013). A second major transcription factor, the activator protein 1 (AP-1), an ubiquitous dimeric protein complex composed of Jun and Fos subfamilies (Curran and Franza, 1988), is also activated by many pathophysiological stimuli, including LPS, reactive oxygen species (ROS), mitogenic growth factors, inflammatory cytokines, growth factors of the transforming growth factor-β (TGF-β family, ultraviolet (UV) and ionizing irradiation, cellular stress, antigen binding, and neoplastic transformation.…”
Section: Anti-inflammatory Activitymentioning
confidence: 99%
“…The factor NF-κB (Section 3.1) promotes the transcription of genes involved in pro-inflammatory responses. In macrophages, NF-κB is activated by inflammatory extracellular signals such as LPS, IL-1 and tumor necrosis factor α (TNF-α), and regulates a number of inflammatory genes, inducing further inflammatory mediators, including NO· and cytokines (Zhang et al, 2013). A second major transcription factor, the activator protein 1 (AP-1), an ubiquitous dimeric protein complex composed of Jun and Fos subfamilies (Curran and Franza, 1988), is also activated by many pathophysiological stimuli, including LPS, reactive oxygen species (ROS), mitogenic growth factors, inflammatory cytokines, growth factors of the transforming growth factor-β (TGF-β family, ultraviolet (UV) and ionizing irradiation, cellular stress, antigen binding, and neoplastic transformation.…”
Section: Anti-inflammatory Activitymentioning
confidence: 99%
“…1), isolated from the barks of Magnolia officinalis, has the ability to cross the blood-brain barrier (Wang et al, 2011). Pharmacologically, honokiol possesses diverse biological activities, including anxiolytic (Kuribara et al, 1999), analgesic (Lin et al, 2009), antidepressant (Xu et al, 2008), antithrombotic (Hu et al, 2005), antimicrobial (Ho et al, 2001), antispasmodic (Ko et al, 2003), anti-tumorigenic (Fried and Arbiser, 2009), and neuroprotective (Zhang et al, 2013) properties. In addition, honokiol has been found to prevent the age-related memory and learning deficits found in senescence-accelerated (SAMP8) mice through preserving cholinergic neurons and enhancing phosphorylation and activity of Akt (Matsui et al, 2009).…”
Section: Introductionmentioning
confidence: 99%
“…Several studies have reported that honokiol induces cell-cycle arrest and apoptosis in cancer cells67 and inhibits tumor-associated lymphangiogenesis and metastasis in lung carcinoma models induced by vascular endothelial growth factor8. Zhang et al 9. discovered novel evidence for the anti-inflammatory effects of honokiol in the treatment of ischemic stroke by inhibiting NF-κB activation.…”
mentioning
confidence: 99%